128 related articles for article (PubMed ID: 26023044)
1. Effects of Silodosin, an α1A-Adrenoceptor Antagonist, and Distigmine, an Acetylcholinesterase Inhibitor, and Their Combined Effects on Impaired Voiding Function in Zucker Diabetic Fatty Rats.
Tatemichi S; Tsuchioka K; Yonekubo S; Maruyama K; Kobayashi M
Pharmacology; 2015; 95(5-6):285-92. PubMed ID: 26023044
[TBL] [Abstract][Full Text] [Related]
2. Alpha
Yonekubo S; Tatemichi S; Maruyama K; Kobayashi M
BMC Urol; 2017 Aug; 17(1):64. PubMed ID: 28835278
[TBL] [Abstract][Full Text] [Related]
3. Effects of α1 antagonist and cholinesterase inhibitor on cystometric parameters in lumbar canal stenosis rats with underactive bladder.
Sekido N; Kida J; Wakamatsu D; Okada H; Matsuya H
Urology; 2014 Nov; 84(5):1248.e9-15. PubMed ID: 25443946
[TBL] [Abstract][Full Text] [Related]
4. Effects of silodosin, a selective α1A-adrenoceptor antagonist, on bladder blood flow and bladder function in a rat model of atherosclerosis induced chronic bladder ischemia without bladder outlet obstruction.
Goi Y; Tomiyama Y; Nomiya M; Sagawa K; Aikawa K; Yamaguchi O
J Urol; 2013 Sep; 190(3):1116-22. PubMed ID: 23545103
[TBL] [Abstract][Full Text] [Related]
5. Effect of silodosin on detrusor overactivity in the male spontaneously hypertensive rat.
Inoue S; Saito M; Tsounapi P; Dimitriadis F; Ohmasa F; Kinoshita Y; Satoh K; Takenaka A
BJU Int; 2012 Jul; 110(2 Pt 2):E118-24. PubMed ID: 22146017
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
J Urol; 2013 Jan; 189(1 Suppl):S117-21. PubMed ID: 23234615
[TBL] [Abstract][Full Text] [Related]
7. Alpha1-adrenoceptor antagonists improve bladder storage function through reduction of afferent activity in rats with bladder outlet obstruction.
Yazaki J; Aikawa K; Shishido K; Yanagida T; Nomiya M; Ishibashi K; Haga N; Yamaguchi O
Neurourol Urodyn; 2011 Mar; 30(3):461-7. PubMed ID: 20886573
[TBL] [Abstract][Full Text] [Related]
8. Effect of silodosin, a selective α(1A)-adrenoceptor antagonist, on voiding behavior and bladder blood flow in a rat model of bladder outlet obstruction.
Goi Y; Tomiyama Y; Yokoyama A; Tatemichi S; Maruyama K; Kobayashi M; Yamaguchi O
Eur J Pharmacol; 2015 Oct; 764():489-496. PubMed ID: 26189024
[TBL] [Abstract][Full Text] [Related]
9. Effects of vibegron, a novel β
Maruyama I; Yamamoto S; Tsuchioka K; Yamazaki T
Eur J Pharmacol; 2020 Jul; 878():173096. PubMed ID: 32259514
[TBL] [Abstract][Full Text] [Related]
10. Synergic Suppressive Effect of Silodosin and Imidafenacin on Non-Voiding Bladder Contractions in Male Rats with Subacute Bladder Outlet Obstruction.
Sugiyama R; Aizawa N; Ito H; Fujimura T; Suzuki M; Nakagawa T; Fukuhara H; Kume H; Homma Y; Igawa Y
Low Urin Tract Symptoms; 2017 May; 9(2):94-101. PubMed ID: 28394493
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of silodosin and urapidil on underactive bladder associated with diabetic cystopathy.
Yonekubo-Awaka S; Tezuka M; Tatemichi S; Takeda H
Low Urin Tract Symptoms; 2022 Nov; 14(6):434-441. PubMed ID: 36059204
[TBL] [Abstract][Full Text] [Related]
12. Effects of TAK-802, a novel acetylcholinesterase inhibitor, and tamsulosin, an alpha1-adrenoceptor antagonist, and their synergistic effects on the urodynamic characteristics in a guinea-pig model of functional bladder outlet obstruction.
Nagabukuro H; Hashimoto T; Iwata M; Doi T
BJU Int; 2005 May; 95(7):1071-6. PubMed ID: 15839935
[TBL] [Abstract][Full Text] [Related]
13. A 12-Week, Open Label, Multi-Center Study to Evaluate the Clinical Efficacy and Safety of Silodosin on Voiding Dysfunction in Patients with Neurogenic Bladder.
Moon KH; Park CH; Jung HC; Oh TH; Kim JS; Kim DY
Low Urin Tract Symptoms; 2015 Jan; 7(1):27-31. PubMed ID: 26663648
[TBL] [Abstract][Full Text] [Related]
14. Effect of distigmine combined with propiverine on bladder activity in rats with spinal cord injury.
Sugaya K; Nishijima S; Kadekawa K; Ashitomi K; Yamamoto H
Int J Urol; 2012 May; 19(5):480-3. PubMed ID: 22221137
[TBL] [Abstract][Full Text] [Related]
15. Urodynamic effects of silodosin, a new alpha 1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia.
Yamanishi T; Mizuno T; Tatsumiya K; Watanabe M; Kamai T; Yoshida K
Neurourol Urodyn; 2010 Apr; 29(4):558-62. PubMed ID: 19693954
[TBL] [Abstract][Full Text] [Related]
16. Characterization of silodosin and naftopidil in the treatment of bladder dysfunction in the spontaneously hypertensive rat.
Saito M; Shimizu S; Ohmasa F; Oikawa R; Tsounapi P; Dimitriadis F; Kinoshita Y; Satoh K
Neurourol Urodyn; 2013 Apr; 32(4):393-8. PubMed ID: 22907830
[TBL] [Abstract][Full Text] [Related]
17. Selective α1A-blocker improves bladder storage function in rats via suppression of C-fiber afferent activity.
Yokoyama O; Ito H; Aoki Y; Oyama N; Miwa Y; Akino H
World J Urol; 2010 Oct; 28(5):609-14. PubMed ID: 19834713
[TBL] [Abstract][Full Text] [Related]
18. Effects of the selective acetylcholinesterase inhibitor TAK-802 on the voiding behavior and bladder mass increase in rats with partial bladder outlet obstruction.
Hashimoto T; Nagabukuro H; Doi T
J Urol; 2005 Sep; 174(3):1137-41. PubMed ID: 16094081
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
J Urol; 2009 Dec; 182(6):2831-5. PubMed ID: 19837428
[TBL] [Abstract][Full Text] [Related]
20. EP2 and EP3 receptors as therapeutic targets for underactive bladder/detrusor underactivity due to diabetic cystopathy in a type 1 diabetic rat model.
Sekido N; Otsuki T; Kida J; Mashimo H; Wakamatsu D; Okada H; Matsuya H
Low Urin Tract Symptoms; 2020 Sep; 12(3):285-291. PubMed ID: 32410343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
